Anti-FCRLA/ FCRL/ FCRL1 functional antibody

Anti-FCRLA/ FCRL/ FCRL1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FCRLA/FCRLA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0213-Ab-1/ GM-Tg-hg-SE0213-Ab-2Anti-Human FCRLA monoclonal antibodyHuman
GM-Tg-rg-SE0213-Ab-1/ GM-Tg-rg-SE0213-Ab-2Anti-Rat FCRLA monoclonal antibodyRat
GM-Tg-mg-SE0213-Ab-1/ GM-Tg-mg-SE0213-Ab-2Anti-Mouse FCRLA monoclonal antibodyMouse
GM-Tg-cynog-SE0213-Ab-1/ GM-Tg-cynog-SE0213-Ab-2Anti-Cynomolgus/ Rhesus macaque FCRLA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0213-Ab-1/ GM-Tg-felg-SE0213-Ab-2Anti-Feline FCRLA monoclonal antibodyFeline
GM-Tg-cang-SE0213-Ab-1/ GM-Tg-cang-SE0213-Ab-2Anti-Canine FCRLA monoclonal antibodyCanine
GM-Tg-bovg-SE0213-Ab-1/ GM-Tg-bovg-SE0213-Ab-2Anti-Bovine FCRLA monoclonal antibodyBovine
GM-Tg-equg-SE0213-Ab-1/ GM-Tg-equg-SE0213-Ab-2Anti-Equine FCRLA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0213-Ab-1/ GM-Tg-hg-SE0213-Ab-2; GM-Tg-rg-SE0213-Ab-1/ GM-Tg-rg-SE0213-Ab-2;
GM-Tg-mg-SE0213-Ab-1/ GM-Tg-mg-SE0213-Ab-2; GM-Tg-cynog-SE0213-Ab-1/ GM-Tg-cynog-SE0213-Ab-2;
GM-Tg-felg-SE0213-Ab-1/ GM-Tg-felg-SE0213-Ab-2; GM-Tg-cang-SE0213-Ab-1/ GM-Tg-cang-SE0213-Ab-2;
GM-Tg-bovg-SE0213-Ab-1/ GM-Tg-bovg-SE0213-Ab-2; GM-Tg-equg-SE0213-Ab-1/ GM-Tg-equg-SE0213-Ab-2
Products NameAnti-FCRLA monoclonal antibody
Formatmab
Target NameFCRLA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCRLA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0213-Ag-1Recombinant multi-species FCRLA/ FCRL/ FCRL1 protein


    Target information

    Target IDGM-SE0213
    Target NameFCRLA
    Gene ID84824,98752,304965,720016,488658,101087297,782871,100051384
    Gene Symbol and SynonymsFCRL,FCRL1,FCRLA,FCRLb,FCRLc1,FCRLc2,FCRLd,FCRLe,FCRLM1,FCRLX,FCRX,FREB,FREB-like,Freb1,mFcrX,mFREB,RGD1306176
    Uniprot AccessionQ7L513,Q3B8P2
    Uniprot Entry NameFCRLA_HUMAN,FCRLA_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132185
    Target ClassificationN/A

    The target: FCRLA, gene name: FCRLA, also named as FCRL, FCRL1, FCRLM1, FCRLX, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRX, FREB. This gene encodes a protein similar to receptors for the Fc fragment of gamma immunoglobulin (IgG). These receptors, referred to as FCGRs, mediate the destruction of IgG-coated antigens and of cells induced by antibodies. This encoded protein is selectively expressed in B cells, and may be involved in their development. This protein may also be involved in the development of lymphomas. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.